Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 2:54 pm Purchase | 13G | INOZYME PHARMA INC INZY | Rock Springs Capital Management LP | 3,086,027 7.64% | 633,390 (+25.82%) | View |
2023-02-14 2:53 pm Purchase | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Rock Springs Capital Management LP | 3,321,066 7.33% | 849,511 (+34.37%) | View |
2023-02-14 2:51 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Rock Springs Capital Management LP | 3,413,906 5.55% | 3,413,906 (New Position) | View |
2023-02-14 2:50 pm Purchase | 13G | AGIOS PHARMACEUTICALS INC AGIO | Rock Springs Capital Management LP | 2,996,592 5.45% | 2,996,592 (New Position) | View |
2023-02-14 2:49 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 3,961,249 5.94% | 99,902 (+2.59%) | View |
2022-04-25 3:05 pm Purchase | 13G | INOZYME PHARMA INC INZY | Rock Springs Capital Management LP | 2,452,637 6.12% | 2,452,637 (New Position) | View |
2022-02-15 12:44 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Rock Springs Capital Management LP | 5,585,621 5.13% | 5,585,621 (New Position) | View |
2022-02-14 6:27 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | Rock Springs Capital Management LP | 0 0% | -643,200 (Position Closed) | View |
2022-02-14 6:27 pm Sale | 13G | F-STAR THERAPEUTICS INC FSTX | Rock Springs Capital Management LP | 751,889 3.65% | -302,343 (-28.68%) | View |
2022-02-14 6:26 pm Sale | 13G | FIVE PRIME THERAPEUTICS INC FPRX | Rock Springs Capital Management LP | 0 0% | -3,041,559 (Position Closed) | View |
2022-02-14 6:26 pm Sale | 13G | CHIASMA INC CHMA | Rock Springs Capital Management LP | 0 0% | -3,243,600 (Position Closed) | View |
2022-02-14 6:26 pm Sale | 13G | ARDELYX INC ARDX | Rock Springs Capital Management LP | 0 0% | -5,148,112 (Position Closed) | View |
2022-02-14 6:25 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | Rock Springs Capital Management LP | 1,184,793 7.87% | 617,435 (+108.83%) | View |
2022-02-14 6:24 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | Rock Springs Capital Management LP | 1,622,689 6.92% | -8,311 (-0.51%) | View |
2022-02-14 6:24 pm Purchase | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | Rock Springs Capital Management LP | 2,581,299 5.37% | 1,266,925 (+96.39%) | View |
2022-02-14 6:23 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,538,814 5.02% | 42,289 (+2.83%) | View |
2022-02-14 6:23 pm Purchase | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | Rock Springs Capital Management LP | 2,471,555 5.64% | 141,770 (+6.09%) | View |
2022-02-14 6:22 pm Purchase | 13G | COMPASS THERAPEUTICS INC CMPX | Rock Springs Capital Management LP | 5,328,088 5.44% | 4,071 (+0.08%) | View |
2022-02-14 6:22 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 3,861,347 6.31% | 1,185,247 (+44.29%) | View |
2022-01-03 4:15 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | Rock Springs Capital Management LP | 823,654 11.48% | 513,493 (+165.56%) | View |